Idenix Pharmaceuticals (IDIX) Misses Q2 EPS by 22c
Tweet
Share
E-mailGet Alerts IDIX Hot Sheet
Join SI Premium – FREE
Idenix Pharmaceuticals (NASDAQ: IDIX) reported Q2 EPS of ($0.43), $0.22 worse than the analyst estimate of ($0.21).
For earnings history and earnings-related data on Idenix Pharmaceuticals (IDIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- BCB Bancorp (BCBP) Misses Q1 EPS by 2c
- MetroCity Bankshares, Inc. (MCBS) Tops Q1 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
